US Patent 9682080 Pyruvate kinase activators for use in therapy
Patent 9682080 was granted and assigned to Agios Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+94 characters)
Article
Patent abstract
Described herein are methods for using compounds that activate pyruvate kinase.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Shin-San Michael Su0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09682080 Pyruvate kinase activators for use in therapy US Patent 9682080 Pyruvate kinase activators for use in therapy
Infobox
Patent Number
096820800
Patent Number
96820800
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
096820800
Date of Patent
June 20, 2017
0Patent Application Number
148867500
Date Filed
October 19, 2015
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09682080 Pyruvate kinase activators for use in therapy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09682080
Date of patent
June 20, 2017
Patent application number
14886750
Date Filed
October 19, 2015
Patent primary examiner
Find more entities like US Patent 9682080 Pyruvate kinase activators for use in therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
